nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—Vinca Alkaloids—Vinblastine—head and neck cancer	0.293	1	CiPCiCtD
Vincristine—Vinblastine—head and neck cancer	0.223	1	CrCtD
Vincristine—muscle cancer—head and neck cancer	0.0584	0.381	CtDrD
Vincristine—Vinorelbine—Vinblastine—head and neck cancer	0.0527	0.379	CrCrCtD
Vincristine—Vindesine—Vinblastine—head and neck cancer	0.0527	0.379	CrCrCtD
Vincristine—peripheral nervous system neoplasm—head and neck cancer	0.0484	0.316	CtDrD
Vincristine—sarcoma—head and neck cancer	0.0466	0.304	CtDrD
Vincristine—Voacamine—Vinblastine—head and neck cancer	0.0337	0.242	CrCrCtD
Vincristine—TUBB4A—Vinblastine—head and neck cancer	0.00865	0.0544	CbGbCtD
Vincristine—TUBB2B—Vinblastine—head and neck cancer	0.00865	0.0544	CbGbCtD
Vincristine—TUBB8—Vinblastine—head and neck cancer	0.00865	0.0544	CbGbCtD
Vincristine—TUBB6—Vinblastine—head and neck cancer	0.00865	0.0544	CbGbCtD
Vincristine—TUBB2A—Vinblastine—head and neck cancer	0.00865	0.0544	CbGbCtD
Vincristine—TUBB3—Vinblastine—head and neck cancer	0.00865	0.0544	CbGbCtD
Vincristine—TUBB—Vinblastine—head and neck cancer	0.00724	0.0455	CbGbCtD
Vincristine—TUBB4B—Vinblastine—head and neck cancer	0.00724	0.0455	CbGbCtD
Vincristine—TUBB1—Vinblastine—head and neck cancer	0.00724	0.0455	CbGbCtD
Vincristine—TUBB8—Docetaxel—head and neck cancer	0.00713	0.0448	CbGbCtD
Vincristine—TUBB6—Docetaxel—head and neck cancer	0.00713	0.0448	CbGbCtD
Vincristine—TUBB2A—Docetaxel—head and neck cancer	0.00713	0.0448	CbGbCtD
Vincristine—TUBB3—Docetaxel—head and neck cancer	0.00713	0.0448	CbGbCtD
Vincristine—TUBB2B—Docetaxel—head and neck cancer	0.00713	0.0448	CbGbCtD
Vincristine—TUBB4A—Docetaxel—head and neck cancer	0.00713	0.0448	CbGbCtD
Vincristine—TUBB1—Docetaxel—head and neck cancer	0.00597	0.0375	CbGbCtD
Vincristine—TUBB4B—Docetaxel—head and neck cancer	0.00597	0.0375	CbGbCtD
Vincristine—TUBB—Docetaxel—head and neck cancer	0.00597	0.0375	CbGbCtD
Vincristine—Complete hearing loss—Vinblastine—head and neck cancer	0.00465	0.241	CcSEcCtD
Vincristine—ABCC10—Docetaxel—head and neck cancer	0.00456	0.0287	CbGbCtD
Vincristine—ABCC3—Fluorouracil—head and neck cancer	0.00375	0.0236	CbGbCtD
Vincristine—ABCB11—Vinblastine—head and neck cancer	0.00301	0.0189	CbGbCtD
Vincristine—ABCC1—Vinblastine—head and neck cancer	0.00214	0.0134	CbGbCtD
Vincristine—ABCC1—Docetaxel—head and neck cancer	0.00176	0.0111	CbGbCtD
Vincristine—ABCC2—Vinblastine—head and neck cancer	0.00158	0.00994	CbGbCtD
Vincristine—ABCG2—Fluorouracil—head and neck cancer	0.00154	0.0097	CbGbCtD
Vincristine—ABCC2—Docetaxel—head and neck cancer	0.0013	0.00819	CbGbCtD
Vincristine—ABCG2—Docetaxel—head and neck cancer	0.00118	0.00741	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.00087	0.00547	CbGbCtD
Vincristine—CYP3A7—Docetaxel—head and neck cancer	0.00087	0.00547	CbGbCtD
Vincristine—CYP3A5—Docetaxel—head and neck cancer	0.000653	0.0041	CbGbCtD
Vincristine—Leukaemia—Hydroxyurea—head and neck cancer	0.000545	0.0283	CcSEcCtD
Vincristine—ABCB1—Vinblastine—head and neck cancer	0.000515	0.00324	CbGbCtD
Vincristine—Pain in jaw—Vinblastine—head and neck cancer	0.000494	0.0256	CcSEcCtD
Vincristine—ABCB1—Docetaxel—head and neck cancer	0.000425	0.00267	CbGbCtD
Vincristine—Peripheral motor neuropathy—Docetaxel—head and neck cancer	0.000417	0.0217	CcSEcCtD
Vincristine—Ileus paralytic—Vinblastine—head and neck cancer	0.000372	0.0193	CcSEcCtD
Vincristine—Septic shock—Fluorouracil—head and neck cancer	0.00035	0.0182	CcSEcCtD
Vincristine—Myelosuppression—Vinblastine—head and neck cancer	0.000343	0.0178	CcSEcCtD
Vincristine—Myelosuppression—Hydroxyurea—head and neck cancer	0.000313	0.0162	CcSEcCtD
Vincristine—CYP3A4—Vinblastine—head and neck cancer	0.000309	0.00194	CbGbCtD
Vincristine—Inappropriate antidiuretic hormone secretion—Vinblastine—head and neck cancer	0.000277	0.0144	CcSEcCtD
Vincristine—CYP3A4—Docetaxel—head and neck cancer	0.000254	0.0016	CbGbCtD
Vincristine—Febrile neutropenia—Hydroxyurea—head and neck cancer	0.000244	0.0127	CcSEcCtD
Vincristine—RALBP1—hair follicle—head and neck cancer	0.000241	0.0338	CbGeAlD
Vincristine—Multi-organ failure—Docetaxel—head and neck cancer	0.000234	0.0121	CcSEcCtD
Vincristine—Ileus—Vinblastine—head and neck cancer	0.000227	0.0118	CcSEcCtD
Vincristine—Nystagmus—Vinblastine—head and neck cancer	0.000225	0.0117	CcSEcCtD
Vincristine—Myelosuppression—Fluorouracil—head and neck cancer	0.000225	0.0117	CcSEcCtD
Vincristine—Bone marrow depression—Hydroxyurea—head and neck cancer	0.000217	0.0113	CcSEcCtD
Vincristine—Neuritis—Vinblastine—head and neck cancer	0.000216	0.0112	CcSEcCtD
Vincristine—Neurotoxicity—Docetaxel—head and neck cancer	0.000197	0.0102	CcSEcCtD
Vincristine—Numbness—Vinblastine—head and neck cancer	0.000194	0.0101	CcSEcCtD
Vincristine—TUBB—hair follicle—head and neck cancer	0.000187	0.0263	CbGeAlD
Vincristine—Sensory loss—Vinblastine—head and neck cancer	0.000186	0.00964	CcSEcCtD
Vincristine—Extravasation—Vinblastine—head and neck cancer	0.000184	0.00957	CcSEcCtD
Vincristine—Febrile neutropenia—Fluorouracil—head and neck cancer	0.000176	0.00911	CcSEcCtD
Vincristine—Bone pain—Vinblastine—head and neck cancer	0.000168	0.00872	CcSEcCtD
Vincristine—Myelosuppression—Docetaxel—head and neck cancer	0.000163	0.00844	CcSEcCtD
Vincristine—TUBB3—connective tissue—head and neck cancer	0.000162	0.0227	CbGeAlD
Vincristine—SLC22A3—tongue—head and neck cancer	0.000161	0.0225	CbGeAlD
Vincristine—TUBB4B—hair follicle—head and neck cancer	0.00016	0.0224	CbGeAlD
Vincristine—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.000158	0.00821	CcSEcCtD
Vincristine—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.000149	0.00776	CcSEcCtD
Vincristine—Nystagmus—Fluorouracil—head and neck cancer	0.000148	0.00768	CcSEcCtD
Vincristine—TUBB8—head—head and neck cancer	0.00014	0.0196	CbGeAlD
Vincristine—TUBA4A—parotid gland—head and neck cancer	0.00014	0.0196	CbGeAlD
Vincristine—TUBA4A—saliva-secreting gland—head and neck cancer	0.000134	0.0187	CbGeAlD
Vincristine—RALBP1—parotid gland—head and neck cancer	0.000132	0.0185	CbGeAlD
Vincristine—Deafness—Vinblastine—head and neck cancer	0.000131	0.00678	CcSEcCtD
Vincristine—Numbness—Fluorouracil—head and neck cancer	0.000127	0.00661	CcSEcCtD
Vincristine—Febrile neutropenia—Docetaxel—head and neck cancer	0.000127	0.00658	CcSEcCtD
Vincristine—RALBP1—saliva-secreting gland—head and neck cancer	0.000126	0.0177	CbGeAlD
Vincristine—TUBA4A—connective tissue—head and neck cancer	0.000123	0.0172	CbGeAlD
Vincristine—Sensory loss—Fluorouracil—head and neck cancer	0.000122	0.00633	CcSEcCtD
Vincristine—Extravasation—Fluorouracil—head and neck cancer	0.000121	0.00628	CcSEcCtD
Vincristine—Hepatic failure—Hydroxyurea—head and neck cancer	0.000119	0.00615	CcSEcCtD
Vincristine—TUBB3—lymphoid tissue—head and neck cancer	0.000118	0.0166	CbGeAlD
Vincristine—TUBA4A—epithelium—head and neck cancer	0.000117	0.0164	CbGeAlD
Vincristine—ABCC1—hair follicle—head and neck cancer	0.000114	0.016	CbGeAlD
Vincristine—Intestinal obstruction—Docetaxel—head and neck cancer	0.000112	0.0058	CcSEcCtD
Vincristine—TUBB2B—parotid gland—head and neck cancer	0.000108	0.0152	CbGeAlD
Vincristine—SLC22A3—mouth—head and neck cancer	0.000108	0.0151	CbGeAlD
Vincristine—Ileus—Docetaxel—head and neck cancer	0.000108	0.00559	CcSEcCtD
Vincristine—TUBB2B—saliva-secreting gland—head and neck cancer	0.000104	0.0145	CbGeAlD
Vincristine—TUBA4A—trachea—head and neck cancer	0.000103	0.0145	CbGeAlD
Vincristine—TUBB—parotid gland—head and neck cancer	0.000102	0.0143	CbGeAlD
Vincristine—Neuritis—Docetaxel—head and neck cancer	0.000102	0.0053	CcSEcCtD
Vincristine—TUBB2A—parotid gland—head and neck cancer	0.000102	0.0143	CbGeAlD
Vincristine—TUBB6—parotid gland—head and neck cancer	0.0001	0.0141	CbGeAlD
Vincristine—TUBB4A—connective tissue—head and neck cancer	9.84e-05	0.0138	CbGeAlD
Vincristine—TUBB—saliva-secreting gland—head and neck cancer	9.8e-05	0.0137	CbGeAlD
Vincristine—TUBB2A—saliva-secreting gland—head and neck cancer	9.75e-05	0.0137	CbGeAlD
Vincristine—RALBP1—trachea—head and neck cancer	9.72e-05	0.0136	CbGeAlD
Vincristine—Coma—Fluorouracil—head and neck cancer	9.65e-05	0.00501	CcSEcCtD
Vincristine—TUBB6—saliva-secreting gland—head and neck cancer	9.61e-05	0.0135	CbGeAlD
Vincristine—Pancytopenia—Vinblastine—head and neck cancer	9.59e-05	0.00498	CcSEcCtD
Vincristine—TUBB3—head—head and neck cancer	9.53e-05	0.0134	CbGeAlD
Vincristine—TUBB2B—connective tissue—head and neck cancer	9.52e-05	0.0133	CbGeAlD
Vincristine—TUBB1—head—head and neck cancer	9.32e-05	0.0131	CbGeAlD
Vincristine—TUBA4A—lymphoid tissue—head and neck cancer	8.98e-05	0.0126	CbGeAlD
Vincristine—Depression—Vinblastine—head and neck cancer	8.98e-05	0.00466	CcSEcCtD
Vincristine—TUBB2A—connective tissue—head and neck cancer	8.96e-05	0.0126	CbGeAlD
Vincristine—Acute coronary syndrome—Vinblastine—head and neck cancer	8.87e-05	0.00461	CcSEcCtD
Vincristine—Neuropathy peripheral—Vinblastine—head and neck cancer	8.82e-05	0.00458	CcSEcCtD
Vincristine—Myocardial infarction—Vinblastine—head and neck cancer	8.82e-05	0.00458	CcSEcCtD
Vincristine—ABCC10—parotid gland—head and neck cancer	8.79e-05	0.0123	CbGeAlD
Vincristine—Pancytopenia—Hydroxyurea—head and neck cancer	8.74e-05	0.00454	CcSEcCtD
Vincristine—Extravasation—Docetaxel—head and neck cancer	8.74e-05	0.00454	CcSEcCtD
Vincristine—TUBB4B—parotid gland—head and neck cancer	8.73e-05	0.0122	CbGeAlD
Vincristine—Neutropenia—Hydroxyurea—head and neck cancer	8.61e-05	0.00447	CcSEcCtD
Vincristine—Dysuria—Hydroxyurea—head and neck cancer	8.61e-05	0.00447	CcSEcCtD
Vincristine—ABCC10—saliva-secreting gland—head and neck cancer	8.42e-05	0.0118	CbGeAlD
Vincristine—TUBB6—epithelium—head and neck cancer	8.39e-05	0.0118	CbGeAlD
Vincristine—TUBB4B—saliva-secreting gland—head and neck cancer	8.36e-05	0.0117	CbGeAlD
Vincristine—Drug interaction—Docetaxel—head and neck cancer	8.22e-05	0.00427	CcSEcCtD
Vincristine—TUBA4A—thyroid gland—head and neck cancer	8.16e-05	0.0114	CbGeAlD
Vincristine—Neuropathy peripheral—Hydroxyurea—head and neck cancer	8.05e-05	0.00418	CcSEcCtD
Vincristine—Hypoaesthesia—Vinblastine—head and neck cancer	8.04e-05	0.00417	CcSEcCtD
Vincristine—Stomatitis—Hydroxyurea—head and neck cancer	8e-05	0.00415	CcSEcCtD
Vincristine—TUBB2B—trachea—head and neck cancer	7.99e-05	0.0112	CbGeAlD
Vincristine—Bone pain—Docetaxel—head and neck cancer	7.96e-05	0.00413	CcSEcCtD
Vincristine—Respiratory failure—Docetaxel—head and neck cancer	7.76e-05	0.00403	CcSEcCtD
Vincristine—RALBP1—thyroid gland—head and neck cancer	7.69e-05	0.0108	CbGeAlD
Vincristine—TUBB4B—connective tissue—head and neck cancer	7.68e-05	0.0108	CbGeAlD
Vincristine—TUBB—trachea—head and neck cancer	7.56e-05	0.0106	CbGeAlD
Vincristine—TUBB2A—trachea—head and neck cancer	7.52e-05	0.0105	CbGeAlD
Vincristine—SLC22A3—parotid gland—head and neck cancer	7.52e-05	0.0105	CbGeAlD
Vincristine—TUBB6—trachea—head and neck cancer	7.42e-05	0.0104	CbGeAlD
Vincristine—Hallucination—Hydroxyurea—head and neck cancer	7.33e-05	0.00381	CcSEcCtD
Vincristine—Cardiac arrest—Fluorouracil—head and neck cancer	7.29e-05	0.00378	CcSEcCtD
Vincristine—TUBA4A—head—head and neck cancer	7.24e-05	0.0102	CbGeAlD
Vincristine—Ataxia—Fluorouracil—head and neck cancer	7.21e-05	0.00374	CcSEcCtD
Vincristine—SLC22A3—saliva-secreting gland—head and neck cancer	7.2e-05	0.0101	CbGeAlD
Vincristine—TUBB4A—lymphoid tissue—head and neck cancer	7.2e-05	0.0101	CbGeAlD
Vincristine—Neuropathy—Docetaxel—head and neck cancer	7.16e-05	0.00372	CcSEcCtD
Vincristine—Alopecia—Vinblastine—head and neck cancer	7.14e-05	0.00371	CcSEcCtD
Vincristine—RALBP1—head—head and neck cancer	6.82e-05	0.00957	CbGeAlD
Vincristine—Muscular weakness—Fluorouracil—head and neck cancer	6.76e-05	0.00351	CcSEcCtD
Vincristine—Angiopathy—Hydroxyurea—head and neck cancer	6.69e-05	0.00347	CcSEcCtD
Vincristine—SLC22A3—connective tissue—head and neck cancer	6.62e-05	0.00928	CbGeAlD
Vincristine—TUBB4A—thyroid gland—head and neck cancer	6.54e-05	0.00917	CbGeAlD
Vincristine—Alopecia—Hydroxyurea—head and neck cancer	6.51e-05	0.00338	CcSEcCtD
Vincristine—Anaemia—Vinblastine—head and neck cancer	6.5e-05	0.00337	CcSEcCtD
Vincristine—ABCC10—trachea—head and neck cancer	6.49e-05	0.00911	CbGeAlD
Vincristine—TUBB6—lymphoid tissue—head and neck cancer	6.46e-05	0.00906	CbGeAlD
Vincristine—TUBB4B—trachea—head and neck cancer	6.45e-05	0.00904	CbGeAlD
Vincristine—Vertigo—Vinblastine—head and neck cancer	6.32e-05	0.00328	CcSEcCtD
Vincristine—TUBB2B—thyroid gland—head and neck cancer	6.32e-05	0.00886	CbGeAlD
Vincristine—Leukopenia—Vinblastine—head and neck cancer	6.3e-05	0.00327	CcSEcCtD
Vincristine—Pancytopenia—Fluorouracil—head and neck cancer	6.29e-05	0.00327	CcSEcCtD
Vincristine—ABCC1—parotid gland—head and neck cancer	6.22e-05	0.00872	CbGeAlD
Vincristine—Deafness—Docetaxel—head and neck cancer	6.19e-05	0.00321	CcSEcCtD
Vincristine—Hepatic failure—Docetaxel—head and neck cancer	6.16e-05	0.0032	CcSEcCtD
Vincristine—Convulsion—Vinblastine—head and neck cancer	6.1e-05	0.00316	CcSEcCtD
Vincristine—Hypertension—Vinblastine—head and neck cancer	6.07e-05	0.00315	CcSEcCtD
Vincristine—Photosensitivity reaction—Fluorouracil—head and neck cancer	6.05e-05	0.00314	CcSEcCtD
Vincristine—TUBB—thyroid gland—head and neck cancer	5.98e-05	0.00839	CbGeAlD
Vincristine—TUBB2A—thyroid gland—head and neck cancer	5.95e-05	0.00834	CbGeAlD
Vincristine—Pneumonia—Fluorouracil—head and neck cancer	5.94e-05	0.00308	CcSEcCtD
Vincristine—Anaemia—Hydroxyurea—head and neck cancer	5.93e-05	0.00308	CcSEcCtD
Vincristine—TUBB6—thyroid gland—head and neck cancer	5.87e-05	0.00823	CbGeAlD
Vincristine—Acute coronary syndrome—Fluorouracil—head and neck cancer	5.83e-05	0.00302	CcSEcCtD
Vincristine—TUBB4A—head—head and neck cancer	5.8e-05	0.00813	CbGeAlD
Vincristine—Neuropathy peripheral—Fluorouracil—head and neck cancer	5.79e-05	0.00301	CcSEcCtD
Vincristine—Myocardial infarction—Fluorouracil—head and neck cancer	5.79e-05	0.00301	CcSEcCtD
Vincristine—Stomatitis—Fluorouracil—head and neck cancer	5.76e-05	0.00299	CcSEcCtD
Vincristine—Leukopenia—Hydroxyurea—head and neck cancer	5.74e-05	0.00298	CcSEcCtD
Vincristine—ABCC10—lymphoid tissue—head and neck cancer	5.66e-05	0.00793	CbGeAlD
Vincristine—Thrombocytopenia—Vinblastine—head and neck cancer	5.62e-05	0.00292	CcSEcCtD
Vincristine—TUBB4B—lymphoid tissue—head and neck cancer	5.61e-05	0.00787	CbGeAlD
Vincristine—TUBB2B—head—head and neck cancer	5.61e-05	0.00786	CbGeAlD
Vincristine—Convulsion—Hydroxyurea—head and neck cancer	5.56e-05	0.00288	CcSEcCtD
Vincristine—Hyponatraemia—Docetaxel—head and neck cancer	5.56e-05	0.00288	CcSEcCtD
Vincristine—Pain in extremity—Docetaxel—head and neck cancer	5.53e-05	0.00287	CcSEcCtD
Vincristine—Anorexia—Vinblastine—head and neck cancer	5.47e-05	0.00284	CcSEcCtD
Vincristine—Hypoaesthesia—Fluorouracil—head and neck cancer	5.28e-05	0.00274	CcSEcCtD
Vincristine—TUBB2A—head—head and neck cancer	5.28e-05	0.0074	CbGeAlD
Vincristine—Oedema—Hydroxyurea—head and neck cancer	5.24e-05	0.00272	CcSEcCtD
Vincristine—TUBB6—head—head and neck cancer	5.2e-05	0.0073	CbGeAlD
Vincristine—Ataxia—Docetaxel—head and neck cancer	5.2e-05	0.0027	CcSEcCtD
Vincristine—Infection—Hydroxyurea—head and neck cancer	5.2e-05	0.0027	CcSEcCtD
Vincristine—ABCC3—thyroid gland—head and neck cancer	5.16e-05	0.00724	CbGeAlD
Vincristine—Paraesthesia—Vinblastine—head and neck cancer	5.16e-05	0.00268	CcSEcCtD
Vincristine—Dehydration—Docetaxel—head and neck cancer	5.15e-05	0.00267	CcSEcCtD
Vincristine—ABCG2—parotid gland—head and neck cancer	5.15e-05	0.00722	CbGeAlD
Vincristine—ABCC10—thyroid gland—head and neck cancer	5.14e-05	0.0072	CbGeAlD
Vincristine—Nervous system disorder—Hydroxyurea—head and neck cancer	5.14e-05	0.00266	CcSEcCtD
Vincristine—Thrombocytopenia—Hydroxyurea—head and neck cancer	5.13e-05	0.00266	CcSEcCtD
Vincristine—TUBB4B—thyroid gland—head and neck cancer	5.1e-05	0.00715	CbGeAlD
Vincristine—TUBA4A—lymph node—head and neck cancer	5.07e-05	0.00711	CbGeAlD
Vincristine—Anorexia—Hydroxyurea—head and neck cancer	4.99e-05	0.00259	CcSEcCtD
Vincristine—Decreased appetite—Vinblastine—head and neck cancer	4.99e-05	0.00259	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	4.98e-05	0.00259	CcSEcCtD
Vincristine—ABCG2—saliva-secreting gland—head and neck cancer	4.93e-05	0.00691	CbGeAlD
Vincristine—Pain—Vinblastine—head and neck cancer	4.91e-05	0.00255	CcSEcCtD
Vincristine—Constipation—Vinblastine—head and neck cancer	4.91e-05	0.00255	CcSEcCtD
Vincristine—RALBP1—lymph node—head and neck cancer	4.78e-05	0.0067	CbGeAlD
Vincristine—Gastrointestinal pain—Vinblastine—head and neck cancer	4.7e-05	0.00244	CcSEcCtD
Vincristine—Alopecia—Fluorouracil—head and neck cancer	4.69e-05	0.00243	CcSEcCtD
Vincristine—ABCC1—trachea—head and neck cancer	4.59e-05	0.00644	CbGeAlD
Vincristine—ABCC3—head—head and neck cancer	4.58e-05	0.00642	CbGeAlD
Vincristine—Decreased appetite—Hydroxyurea—head and neck cancer	4.55e-05	0.00236	CcSEcCtD
Vincristine—Pancytopenia—Docetaxel—head and neck cancer	4.54e-05	0.00236	CcSEcCtD
Vincristine—Abdominal pain—Vinblastine—head and neck cancer	4.54e-05	0.00236	CcSEcCtD
Vincristine—TUBB4B—head—head and neck cancer	4.52e-05	0.00635	CbGeAlD
Vincristine—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	4.52e-05	0.00235	CcSEcCtD
Vincristine—Fatigue—Hydroxyurea—head and neck cancer	4.51e-05	0.00234	CcSEcCtD
Vincristine—Pain—Hydroxyurea—head and neck cancer	4.48e-05	0.00232	CcSEcCtD
Vincristine—Constipation—Hydroxyurea—head and neck cancer	4.48e-05	0.00232	CcSEcCtD
Vincristine—Neutropenia—Docetaxel—head and neck cancer	4.47e-05	0.00232	CcSEcCtD
Vincristine—SLC22A3—thyroid gland—head and neck cancer	4.39e-05	0.00616	CbGeAlD
Vincristine—Weight decreased—Docetaxel—head and neck cancer	4.33e-05	0.00225	CcSEcCtD
Vincristine—Pneumonia—Docetaxel—head and neck cancer	4.29e-05	0.00223	CcSEcCtD
Vincristine—Anaemia—Fluorouracil—head and neck cancer	4.27e-05	0.00222	CcSEcCtD
Vincristine—Hypersensitivity—Vinblastine—head and neck cancer	4.23e-05	0.0022	CcSEcCtD
Vincristine—Acute coronary syndrome—Docetaxel—head and neck cancer	4.2e-05	0.00218	CcSEcCtD
Vincristine—Neuropathy peripheral—Docetaxel—head and neck cancer	4.18e-05	0.00217	CcSEcCtD
Vincristine—Myocardial infarction—Docetaxel—head and neck cancer	4.18e-05	0.00217	CcSEcCtD
Vincristine—Stomatitis—Docetaxel—head and neck cancer	4.16e-05	0.00216	CcSEcCtD
Vincristine—Body temperature increased—Hydroxyurea—head and neck cancer	4.14e-05	0.00215	CcSEcCtD
Vincristine—Leukopenia—Fluorouracil—head and neck cancer	4.13e-05	0.00215	CcSEcCtD
Vincristine—Asthenia—Vinblastine—head and neck cancer	4.12e-05	0.00214	CcSEcCtD
Vincristine—TUBB4A—lymph node—head and neck cancer	4.06e-05	0.0057	CbGeAlD
Vincristine—Convulsion—Fluorouracil—head and neck cancer	4e-05	0.00208	CcSEcCtD
Vincristine—Myalgia—Fluorouracil—head and neck cancer	3.93e-05	0.00204	CcSEcCtD
Vincristine—Diarrhoea—Vinblastine—head and neck cancer	3.93e-05	0.00204	CcSEcCtD
Vincristine—TUBB2B—lymph node—head and neck cancer	3.93e-05	0.00551	CbGeAlD
Vincristine—SLC22A3—head—head and neck cancer	3.9e-05	0.00547	CbGeAlD
Vincristine—Hypersensitivity—Hydroxyurea—head and neck cancer	3.86e-05	0.002	CcSEcCtD
Vincristine—Hypoaesthesia—Docetaxel—head and neck cancer	3.81e-05	0.00198	CcSEcCtD
Vincristine—Dizziness—Vinblastine—head and neck cancer	3.8e-05	0.00197	CcSEcCtD
Vincristine—Urinary tract disorder—Docetaxel—head and neck cancer	3.78e-05	0.00196	CcSEcCtD
Vincristine—Oedema—Fluorouracil—head and neck cancer	3.77e-05	0.00196	CcSEcCtD
Vincristine—Anaphylactic shock—Fluorouracil—head and neck cancer	3.77e-05	0.00196	CcSEcCtD
Vincristine—Connective tissue disorder—Docetaxel—head and neck cancer	3.76e-05	0.00195	CcSEcCtD
Vincristine—Asthenia—Hydroxyurea—head and neck cancer	3.76e-05	0.00195	CcSEcCtD
Vincristine—Urethral disorder—Docetaxel—head and neck cancer	3.75e-05	0.00195	CcSEcCtD
Vincristine—Infection—Fluorouracil—head and neck cancer	3.74e-05	0.00194	CcSEcCtD
Vincristine—TUBB—lymph node—head and neck cancer	3.71e-05	0.00521	CbGeAlD
Vincristine—Nervous system disorder—Fluorouracil—head and neck cancer	3.7e-05	0.00192	CcSEcCtD
Vincristine—TUBB2A—lymph node—head and neck cancer	3.7e-05	0.00518	CbGeAlD
Vincristine—Thrombocytopenia—Fluorouracil—head and neck cancer	3.69e-05	0.00192	CcSEcCtD
Vincristine—Vomiting—Vinblastine—head and neck cancer	3.65e-05	0.00189	CcSEcCtD
Vincristine—TUBB6—lymph node—head and neck cancer	3.64e-05	0.00511	CbGeAlD
Vincristine—ABCC1—thyroid gland—head and neck cancer	3.63e-05	0.0051	CbGeAlD
Vincristine—Headache—Vinblastine—head and neck cancer	3.6e-05	0.00187	CcSEcCtD
Vincristine—Anorexia—Fluorouracil—head and neck cancer	3.59e-05	0.00186	CcSEcCtD
Vincristine—Diarrhoea—Hydroxyurea—head and neck cancer	3.58e-05	0.00186	CcSEcCtD
Vincristine—Cardiac disorder—Docetaxel—head and neck cancer	3.55e-05	0.00184	CcSEcCtD
Vincristine—Hypotension—Fluorouracil—head and neck cancer	3.52e-05	0.00183	CcSEcCtD
Vincristine—Angiopathy—Docetaxel—head and neck cancer	3.47e-05	0.0018	CcSEcCtD
Vincristine—Dizziness—Hydroxyurea—head and neck cancer	3.46e-05	0.0018	CcSEcCtD
Vincristine—Mediastinal disorder—Docetaxel—head and neck cancer	3.45e-05	0.00179	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	3.43e-05	0.00178	CcSEcCtD
Vincristine—Nausea—Vinblastine—head and neck cancer	3.41e-05	0.00177	CcSEcCtD
Vincristine—Insomnia—Fluorouracil—head and neck cancer	3.41e-05	0.00177	CcSEcCtD
Vincristine—Paraesthesia—Fluorouracil—head and neck cancer	3.38e-05	0.00176	CcSEcCtD
Vincristine—Alopecia—Docetaxel—head and neck cancer	3.38e-05	0.00176	CcSEcCtD
Vincristine—Mental disorder—Docetaxel—head and neck cancer	3.35e-05	0.00174	CcSEcCtD
Vincristine—Vomiting—Hydroxyurea—head and neck cancer	3.33e-05	0.00173	CcSEcCtD
Vincristine—Rash—Hydroxyurea—head and neck cancer	3.3e-05	0.00171	CcSEcCtD
Vincristine—Dermatitis—Hydroxyurea—head and neck cancer	3.3e-05	0.00171	CcSEcCtD
Vincristine—Headache—Hydroxyurea—head and neck cancer	3.28e-05	0.0017	CcSEcCtD
Vincristine—Decreased appetite—Fluorouracil—head and neck cancer	3.28e-05	0.0017	CcSEcCtD
Vincristine—Gastrointestinal disorder—Fluorouracil—head and neck cancer	3.25e-05	0.00169	CcSEcCtD
Vincristine—Back pain—Docetaxel—head and neck cancer	3.22e-05	0.00167	CcSEcCtD
Vincristine—Pain—Fluorouracil—head and neck cancer	3.22e-05	0.00167	CcSEcCtD
Vincristine—ABCC3—lymph node—head and neck cancer	3.21e-05	0.0045	CbGeAlD
Vincristine—ABCC10—lymph node—head and neck cancer	3.19e-05	0.00448	CbGeAlD
Vincristine—TUBB4B—lymph node—head and neck cancer	3.17e-05	0.00444	CbGeAlD
Vincristine—Nausea—Hydroxyurea—head and neck cancer	3.11e-05	0.00161	CcSEcCtD
Vincristine—Anaemia—Docetaxel—head and neck cancer	3.08e-05	0.0016	CcSEcCtD
Vincristine—ABCG2—thyroid gland—head and neck cancer	3.01e-05	0.00422	CbGeAlD
Vincristine—Leukopenia—Docetaxel—head and neck cancer	2.98e-05	0.00155	CcSEcCtD
Vincristine—Body temperature increased—Fluorouracil—head and neck cancer	2.98e-05	0.00155	CcSEcCtD
Vincristine—Convulsion—Docetaxel—head and neck cancer	2.89e-05	0.0015	CcSEcCtD
Vincristine—Hypertension—Docetaxel—head and neck cancer	2.88e-05	0.00149	CcSEcCtD
Vincristine—Myalgia—Docetaxel—head and neck cancer	2.84e-05	0.00147	CcSEcCtD
Vincristine—Hypersensitivity—Fluorouracil—head and neck cancer	2.78e-05	0.00144	CcSEcCtD
Vincristine—SLC22A3—lymph node—head and neck cancer	2.73e-05	0.00383	CbGeAlD
Vincristine—Anaphylactic shock—Docetaxel—head and neck cancer	2.72e-05	0.00141	CcSEcCtD
Vincristine—Oedema—Docetaxel—head and neck cancer	2.72e-05	0.00141	CcSEcCtD
Vincristine—Infection—Docetaxel—head and neck cancer	2.7e-05	0.0014	CcSEcCtD
Vincristine—Nervous system disorder—Docetaxel—head and neck cancer	2.67e-05	0.00138	CcSEcCtD
Vincristine—Thrombocytopenia—Docetaxel—head and neck cancer	2.66e-05	0.00138	CcSEcCtD
Vincristine—Anorexia—Docetaxel—head and neck cancer	2.59e-05	0.00135	CcSEcCtD
Vincristine—Diarrhoea—Fluorouracil—head and neck cancer	2.58e-05	0.00134	CcSEcCtD
Vincristine—ABCC2—lymph node—head and neck cancer	2.56e-05	0.00359	CbGeAlD
Vincristine—Hypotension—Docetaxel—head and neck cancer	2.54e-05	0.00132	CcSEcCtD
Vincristine—Dizziness—Fluorouracil—head and neck cancer	2.49e-05	0.00129	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Docetaxel—head and neck cancer	2.48e-05	0.00129	CcSEcCtD
Vincristine—Insomnia—Docetaxel—head and neck cancer	2.46e-05	0.00128	CcSEcCtD
Vincristine—Paraesthesia—Docetaxel—head and neck cancer	2.44e-05	0.00127	CcSEcCtD
Vincristine—Vomiting—Fluorouracil—head and neck cancer	2.4e-05	0.00124	CcSEcCtD
Vincristine—Rash—Fluorouracil—head and neck cancer	2.38e-05	0.00123	CcSEcCtD
Vincristine—Dermatitis—Fluorouracil—head and neck cancer	2.37e-05	0.00123	CcSEcCtD
Vincristine—Decreased appetite—Docetaxel—head and neck cancer	2.36e-05	0.00123	CcSEcCtD
Vincristine—Headache—Fluorouracil—head and neck cancer	2.36e-05	0.00123	CcSEcCtD
Vincristine—Gastrointestinal disorder—Docetaxel—head and neck cancer	2.35e-05	0.00122	CcSEcCtD
Vincristine—Fatigue—Docetaxel—head and neck cancer	2.35e-05	0.00122	CcSEcCtD
Vincristine—Constipation—Docetaxel—head and neck cancer	2.33e-05	0.00121	CcSEcCtD
Vincristine—Pain—Docetaxel—head and neck cancer	2.33e-05	0.00121	CcSEcCtD
Vincristine—ABCC1—lymph node—head and neck cancer	2.26e-05	0.00317	CbGeAlD
Vincristine—Nausea—Fluorouracil—head and neck cancer	2.24e-05	0.00116	CcSEcCtD
Vincristine—Gastrointestinal pain—Docetaxel—head and neck cancer	2.22e-05	0.00115	CcSEcCtD
Vincristine—Abdominal pain—Docetaxel—head and neck cancer	2.15e-05	0.00112	CcSEcCtD
Vincristine—Body temperature increased—Docetaxel—head and neck cancer	2.15e-05	0.00112	CcSEcCtD
Vincristine—ABCB1—epithelium—head and neck cancer	2.12e-05	0.00297	CbGeAlD
Vincristine—Hypersensitivity—Docetaxel—head and neck cancer	2e-05	0.00104	CcSEcCtD
Vincristine—Asthenia—Docetaxel—head and neck cancer	1.95e-05	0.00101	CcSEcCtD
Vincristine—ABCB1—trachea—head and neck cancer	1.87e-05	0.00263	CbGeAlD
Vincristine—ABCG2—lymph node—head and neck cancer	1.87e-05	0.00262	CbGeAlD
Vincristine—Diarrhoea—Docetaxel—head and neck cancer	1.86e-05	0.000966	CcSEcCtD
Vincristine—Dizziness—Docetaxel—head and neck cancer	1.8e-05	0.000934	CcSEcCtD
Vincristine—Vomiting—Docetaxel—head and neck cancer	1.73e-05	0.000898	CcSEcCtD
Vincristine—Rash—Docetaxel—head and neck cancer	1.72e-05	0.00089	CcSEcCtD
Vincristine—Dermatitis—Docetaxel—head and neck cancer	1.71e-05	0.000889	CcSEcCtD
Vincristine—Headache—Docetaxel—head and neck cancer	1.7e-05	0.000884	CcSEcCtD
Vincristine—ABCB1—lymphoid tissue—head and neck cancer	1.63e-05	0.00229	CbGeAlD
Vincristine—Nausea—Docetaxel—head and neck cancer	1.62e-05	0.000839	CcSEcCtD
Vincristine—ABCB1—thyroid gland—head and neck cancer	1.48e-05	0.00208	CbGeAlD
Vincristine—ABCB1—head—head and neck cancer	1.32e-05	0.00185	CbGeAlD
Vincristine—ABCC3—Metabolism—UROD—head and neck cancer	1.11e-05	0.00216	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—RAD51—head and neck cancer	1.09e-05	0.00213	CbGpPWpGaD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—AKT1—head and neck cancer	1.08e-05	0.00211	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—IL2—head and neck cancer	1.08e-05	0.0021	CbGpPWpGaD
Vincristine—TUBB4B—Metabolism of proteins—GRP—head and neck cancer	1.06e-05	0.00206	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—GRP—head and neck cancer	1.02e-05	0.00199	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TYMS—head and neck cancer	1.02e-05	0.00198	CbGpPWpGaD
Vincristine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—head and neck cancer	1.01e-05	0.00197	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—STAT6—head and neck cancer	9.92e-06	0.00193	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	9.84e-06	0.00192	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	9.72e-06	0.00189	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—TYMS—head and neck cancer	9.67e-06	0.00188	CbGpPWpGaD
Vincristine—ABCB1—lymph node—head and neck cancer	9.21e-06	0.00129	CbGeAlD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	9.18e-06	0.00179	CbGpPWpGaD
Vincristine—CYP3A7—Biological oxidations—GSTM1—head and neck cancer	9.07e-06	0.00177	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.95e-06	0.00174	CbGpPWpGaD
Vincristine—CYP3A7—Metapathway biotransformation—GSTM1—head and neck cancer	8.94e-06	0.00174	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—YAP1—head and neck cancer	8.78e-06	0.00171	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	8.74e-06	0.0017	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	8.68e-06	0.00169	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—UROD—head and neck cancer	8.67e-06	0.00169	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TYMS—head and neck cancer	8.65e-06	0.00169	CbGpPWpGaD
Vincristine—CYP3A7—Biological oxidations—CYP1A1—head and neck cancer	8.6e-06	0.00167	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.58e-06	0.00167	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—ATP7B—head and neck cancer	8.56e-06	0.00167	CbGpPWpGaD
Vincristine—CYP3A7—Metapathway biotransformation—CYP1A1—head and neck cancer	8.48e-06	0.00165	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	8.42e-06	0.00164	CbGpPWpGaD
Vincristine—CYP3A4—Tryptophan metabolism—CYP1A1—head and neck cancer	8.3e-06	0.00162	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	8.26e-06	0.00161	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—TYMS—head and neck cancer	8.02e-06	0.00156	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	7.66e-06	0.00149	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—UROD—head and neck cancer	7.63e-06	0.00149	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—UROD—head and neck cancer	7.56e-06	0.00147	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—TYMS—head and neck cancer	7.33e-06	0.00143	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	7.17e-06	0.0014	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TYMS—head and neck cancer	7.17e-06	0.0014	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.73e-06	0.00131	CbGpPWpGaD
Vincristine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	6.71e-06	0.00131	CbGpPWpGaD
Vincristine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	6.62e-06	0.00129	CbGpPWpGaD
Vincristine—CYP3A5—Biological oxidations—GSTM1—head and neck cancer	6.56e-06	0.00128	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TYMS—head and neck cancer	6.56e-06	0.00128	CbGpPWpGaD
Vincristine—CYP3A5—Metapathway biotransformation—GSTM1—head and neck cancer	6.47e-06	0.00126	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—CASP8—head and neck cancer	6.37e-06	0.00124	CbGpPWpGaD
Vincristine—CYP3A5—Biological oxidations—CYP1A1—head and neck cancer	6.21e-06	0.00121	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—NAT2—head and neck cancer	6.17e-06	0.0012	CbGpPWpGaD
Vincristine—CYP3A5—Metapathway biotransformation—CYP1A1—head and neck cancer	6.13e-06	0.00119	CbGpPWpGaD
Vincristine—CYP3A4—Metapathway biotransformation—NAT2—head and neck cancer	6.09e-06	0.00119	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	5.86e-06	0.00114	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CCND1—head and neck cancer	5.73e-06	0.00112	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—NOTCH1—head and neck cancer	5.72e-06	0.00111	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	5.58e-06	0.00109	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—IL2—head and neck cancer	5.57e-06	0.00108	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—UROD—head and neck cancer	5.47e-06	0.00106	CbGpPWpGaD
Vincristine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	5.44e-06	0.00106	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CCND1—head and neck cancer	5.12e-06	0.000998	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.09e-06	0.000992	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.04e-06	0.000982	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—NAT2—head and neck cancer	5e-06	0.000974	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.88e-06	0.000951	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CCND1—head and neck cancer	4.87e-06	0.000949	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.83e-06	0.000941	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—IL2—head and neck cancer	4.82e-06	0.000938	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—NAT2—head and neck cancer	4.79e-06	0.000934	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—VEGFA—head and neck cancer	4.73e-06	0.000922	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—head and neck cancer	4.73e-06	0.000921	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	4.72e-06	0.00092	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—ATP7B—head and neck cancer	4.63e-06	0.000901	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	4.6e-06	0.000896	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—NAT2—head and neck cancer	4.59e-06	0.000895	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	4.5e-06	0.000876	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—MAPK3—head and neck cancer	4.48e-06	0.000872	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—DPYD—head and neck cancer	4.38e-06	0.000854	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CCND1—head and neck cancer	4.36e-06	0.000848	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—MAPK1—head and neck cancer	4.26e-06	0.00083	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MAPK3—head and neck cancer	4.22e-06	0.000823	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—DPYD—head and neck cancer	4.2e-06	0.000819	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—YAP1—head and neck cancer	4.16e-06	0.00081	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—UROD—head and neck cancer	4.12e-06	0.000804	CbGpPWpGaD
Vincristine—ABCB1—Allograft Rejection—VEGFA—head and neck cancer	4.09e-06	0.000797	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CCND1—head and neck cancer	4.04e-06	0.000786	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—DPYD—head and neck cancer	4.03e-06	0.000785	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—MAPK1—head and neck cancer	4.02e-06	0.000783	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—MAPK3—head and neck cancer	4.02e-06	0.000783	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—YAP1—head and neck cancer	3.99e-06	0.000777	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—NOTCH1—head and neck cancer	3.96e-06	0.000771	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.82e-06	0.000745	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—YAP1—head and neck cancer	3.82e-06	0.000745	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—MAPK1—head and neck cancer	3.82e-06	0.000745	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.79e-06	0.000737	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—PIK3CA—head and neck cancer	3.7e-06	0.00072	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CCND1—head and neck cancer	3.69e-06	0.000719	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CCND1—head and neck cancer	3.61e-06	0.000703	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—NAT2—head and neck cancer	3.6e-06	0.000701	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MAPK3—head and neck cancer	3.59e-06	0.0007	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TP53—head and neck cancer	3.58e-06	0.000696	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—HRAS—head and neck cancer	3.42e-06	0.000666	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—MAPK1—head and neck cancer	3.42e-06	0.000666	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TP53—head and neck cancer	3.37e-06	0.000657	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MAPK3—head and neck cancer	3.33e-06	0.000648	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CCND1—head and neck cancer	3.3e-06	0.000643	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—NAT2—head and neck cancer	3.17e-06	0.000617	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—MAPK1—head and neck cancer	3.17e-06	0.000617	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—MAPK3—head and neck cancer	3.17e-06	0.000617	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—DPYD—head and neck cancer	3.16e-06	0.000615	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	3.15e-06	0.000613	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—NAT2—head and neck cancer	3.14e-06	0.000612	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—GSTM1—head and neck cancer	3.05e-06	0.000594	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MAPK3—head and neck cancer	3.04e-06	0.000593	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—AKT1—head and neck cancer	3.02e-06	0.000588	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—AKT1—head and neck cancer	3.02e-06	0.000588	CbGpPWpGaD
Vincristine—CYP3A4—Metapathway biotransformation—GSTM1—head and neck cancer	3.01e-06	0.000586	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3e-06	0.000584	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—YAP1—head and neck cancer	3e-06	0.000584	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MAPK3—head and neck cancer	2.98e-06	0.00058	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—MAPK1—head and neck cancer	2.9e-06	0.000564	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—CYP1A1—head and neck cancer	2.89e-06	0.000563	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.87e-06	0.00056	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TP53—head and neck cancer	2.87e-06	0.000559	CbGpPWpGaD
Vincristine—CYP3A4—Metapathway biotransformation—CYP1A1—head and neck cancer	2.85e-06	0.000555	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—MAPK1—head and neck cancer	2.83e-06	0.000552	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—DPYD—head and neck cancer	2.78e-06	0.000541	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—DPYD—head and neck cancer	2.75e-06	0.000536	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—IL2—head and neck cancer	2.72e-06	0.00053	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MAPK3—head and neck cancer	2.72e-06	0.00053	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	2.7e-06	0.000526	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCND1—head and neck cancer	2.65e-06	0.000517	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—YAP1—head and neck cancer	2.64e-06	0.000514	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.61e-06	0.000509	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—YAP1—head and neck cancer	2.61e-06	0.000509	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—MAPK1—head and neck cancer	2.59e-06	0.000505	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	2.56e-06	0.0005	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PTEN—head and neck cancer	2.56e-06	0.000499	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—UROD—head and neck cancer	2.54e-06	0.000495	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.51e-06	0.000488	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—TYMS—head and neck cancer	2.5e-06	0.000487	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GSTM1—head and neck cancer	2.47e-06	0.000481	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—TYMS—head and neck cancer	2.39e-06	0.000466	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TP53—head and neck cancer	2.38e-06	0.000463	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GSTM1—head and neck cancer	2.37e-06	0.000461	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—GPX1—head and neck cancer	2.36e-06	0.000461	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—CYP1A1—head and neck cancer	2.34e-06	0.000456	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	2.32e-06	0.000451	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—VEGFA—head and neck cancer	2.31e-06	0.000451	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—TYMS—head and neck cancer	2.3e-06	0.000447	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—STAT3—head and neck cancer	2.29e-06	0.000446	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—NAT2—head and neck cancer	2.27e-06	0.000442	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GSTM1—head and neck cancer	2.27e-06	0.000442	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—GPX1—head and neck cancer	2.27e-06	0.000442	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.25e-06	0.000439	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CYP1A1—head and neck cancer	2.24e-06	0.000437	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	2.24e-06	0.000436	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MAPK3—head and neck cancer	2.19e-06	0.000426	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TP53—head and neck cancer	2.17e-06	0.000424	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—GPX1—head and neck cancer	2.17e-06	0.000423	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CYP1A1—head and neck cancer	2.15e-06	0.000419	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—AKT1—head and neck cancer	2.14e-06	0.000416	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MAPK1—head and neck cancer	2.08e-06	0.000406	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—EGFR—head and neck cancer	2.08e-06	0.000406	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	2.02e-06	0.000394	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—DPYD—head and neck cancer	1.99e-06	0.000388	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.96e-06	0.000382	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	1.91e-06	0.000372	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—YAP1—head and neck cancer	1.89e-06	0.000368	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.84e-06	0.000359	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.82e-06	0.000354	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.82e-06	0.000354	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PIK3CA—head and neck cancer	1.81e-06	0.000352	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—TYMS—head and neck cancer	1.8e-06	0.00035	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GSTM1—head and neck cancer	1.78e-06	0.000346	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.77e-06	0.000344	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TP53—head and neck cancer	1.75e-06	0.000341	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—NAT2—head and neck cancer	1.71e-06	0.000334	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—GPX1—head and neck cancer	1.7e-06	0.000332	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CYP1A1—head and neck cancer	1.69e-06	0.000328	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HRAS—head and neck cancer	1.67e-06	0.000326	CbGpPWpGaD
Vincristine—ABCC1—Disease—NOTCH1—head and neck cancer	1.61e-06	0.000314	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—TYMS—head and neck cancer	1.58e-06	0.000308	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.58e-06	0.000307	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—TYMS—head and neck cancer	1.57e-06	0.000306	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GSTM1—head and neck cancer	1.56e-06	0.000305	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GSTM1—head and neck cancer	1.55e-06	0.000302	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.53e-06	0.000297	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—DPYD—head and neck cancer	1.5e-06	0.000293	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—GPX1—head and neck cancer	1.5e-06	0.000292	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—GPX1—head and neck cancer	1.49e-06	0.000289	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CYP1A1—head and neck cancer	1.48e-06	0.000289	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—AKT1—head and neck cancer	1.48e-06	0.000288	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CYP1A1—head and neck cancer	1.47e-06	0.000286	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—YAP1—head and neck cancer	1.43e-06	0.000278	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTGS2—head and neck cancer	1.39e-06	0.000271	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.38e-06	0.00027	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTGS2—head and neck cancer	1.33e-06	0.00026	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.29e-06	0.000251	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTGS2—head and neck cancer	1.28e-06	0.000249	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTEN—head and neck cancer	1.21e-06	0.000236	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTGS2—head and neck cancer	1.2e-06	0.000233	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTEN—head and neck cancer	1.16e-06	0.000227	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—TYMS—head and neck cancer	1.13e-06	0.000221	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GSTM1—head and neck cancer	1.12e-06	0.000218	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTEN—head and neck cancer	1.12e-06	0.000217	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—GPX1—head and neck cancer	1.07e-06	0.000209	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CYP1A1—head and neck cancer	1.06e-06	0.000207	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NAT2—head and neck cancer	1.06e-06	0.000206	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTEN—head and neck cancer	1.04e-06	0.000203	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTGS2—head and neck cancer	1e-06	0.000195	CbGpPWpGaD
Vincristine—ABCC1—Disease—STAT3—head and neck cancer	9.34e-07	0.000182	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—DPYD—head and neck cancer	9.25e-07	0.00018	CbGpPWpGaD
Vincristine—ABCC1—Disease—MAPK3—head and neck cancer	8.92e-07	0.000174	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTGS2—head and neck cancer	8.82e-07	0.000172	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—YAP1—head and neck cancer	8.78e-07	0.000171	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTGS2—head and neck cancer	8.74e-07	0.00017	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTEN—head and neck cancer	8.74e-07	0.00017	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PIK3CA—head and neck cancer	8.56e-07	0.000167	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—TYMS—head and neck cancer	8.56e-07	0.000167	CbGpPWpGaD
Vincristine—ABCC1—Disease—MAPK1—head and neck cancer	8.49e-07	0.000165	CbGpPWpGaD
Vincristine—ABCC1—Disease—EGFR—head and neck cancer	8.49e-07	0.000165	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GSTM1—head and neck cancer	8.46e-07	0.000165	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PIK3CA—head and neck cancer	8.21e-07	0.00016	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—GPX1—head and neck cancer	8.1e-07	0.000158	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CYP1A1—head and neck cancer	8.02e-07	0.000156	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PIK3CA—head and neck cancer	7.87e-07	0.000153	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTEN—head and neck cancer	7.69e-07	0.00015	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTEN—head and neck cancer	7.62e-07	0.000149	CbGpPWpGaD
Vincristine—ABCC1—Disease—PIK3CA—head and neck cancer	7.36e-07	0.000143	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—AKT1—head and neck cancer	7e-07	0.000136	CbGpPWpGaD
Vincristine—ABCC1—Disease—HRAS—head and neck cancer	6.81e-07	0.000133	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—AKT1—head and neck cancer	6.71e-07	0.000131	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—AKT1—head and neck cancer	6.43e-07	0.000125	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTGS2—head and neck cancer	6.32e-07	0.000123	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PIK3CA—head and neck cancer	6.17e-07	0.00012	CbGpPWpGaD
Vincristine—ABCC1—Disease—AKT1—head and neck cancer	6.02e-07	0.000117	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTEN—head and neck cancer	5.51e-07	0.000107	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PIK3CA—head and neck cancer	5.43e-07	0.000106	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PIK3CA—head and neck cancer	5.38e-07	0.000105	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—TYMS—head and neck cancer	5.27e-07	0.000103	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GSTM1—head and neck cancer	5.21e-07	0.000102	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—AKT1—head and neck cancer	5.04e-07	9.82e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—GPX1—head and neck cancer	4.99e-07	9.72e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CYP1A1—head and neck cancer	4.94e-07	9.63e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTGS2—head and neck cancer	4.77e-07	9.29e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—AKT1—head and neck cancer	4.43e-07	8.64e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—AKT1—head and neck cancer	4.39e-07	8.56e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTEN—head and neck cancer	4.16e-07	8.1e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PIK3CA—head and neck cancer	3.89e-07	7.57e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—AKT1—head and neck cancer	3.18e-07	6.19e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.94e-07	5.72e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.93e-07	5.72e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTEN—head and neck cancer	2.56e-07	4.99e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—AKT1—head and neck cancer	2.4e-07	4.67e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.81e-07	3.52e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—AKT1—head and neck cancer	1.48e-07	2.88e-05	CbGpPWpGaD
